SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-040453
Filing Date
2023-02-16
Accepted
2023-02-15 19:45:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d442043dsc13ga.htm SC 13G/A 38518
  Complete submission text file 0001193125-23-040453.txt   39795
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Subject) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92155 | Film No.: 23636846
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address
Werner Milton H. (Filed by) CIK: 0001827621 (see all company filings)

Type: SC 13G/A